01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#TSP TruSpine Technologies PLC – Half-year Report December 30, 2025 – Posted in: Uncategorized

The Company continues to be in a pre-revenue development phase and remains loss-making.  The loss before taxation for the six months to 30 September 2025 was £335k (2024: £410k) after administrative expenses of £335k (2024: £410k). Consolidated net assets as at 30 September 2025 amounted to £1.83 million (2024: £2.33 million) including a bank balance of £33k as at 30 September 2025 (2024: £51k). As highlighted in recent shareholder communications, until discussions regarding the long-term…

Continue reading

#POLB Poolbeg Pharma PLC – POLB 001 Patent Granted in Korea March 20, 2025 – Posted in: Poolbeg Pharma (POLB)

20 March 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that the Korean Intellectual Property Office has notified the Company of its official decision to grant Poolbeg’s Republic of Korea Immunomodulator II patent application providing protection to POLB 001 for the treatment of severe influenza to December 2038.   POLB 001 is a potent and selective p38 MAP…

Continue reading

Alpha Prospects – MSAART Chimney Technology Licence – India March 13, 2024 – Posted in: Alpha Prospects Ltd, Blog

“This technology provides unprecedented reduction in harmful emissions whilst simultaneously increasing oxygen levels from near zero to normal atmospheric levels in coal and wood burning power plants.” Alpha Prospects Ltd, the investment management company focussed on innovative energy solutions, is pleased to announce that it has entered into an agreement with Strike Foundation Guarantee Limited, (STRIKE Foundation”); Strategic Technology Resources Industry Knowledge and Empowerment (STRIKE) and Strike Ground Zero Ltd (SGZ) to license the intellectual…

Continue reading